
Opinion|Videos|May 15, 2024
FDA-approved Therapies for Geographic Atrophy
An expert retina specialist discusses the recent FDA-approved treatments for geographic atrophy (GA) that slow disease progression and highlights key factors to consider before starting treatment.
Advertisement
Newsletter
Keep your retina practice on the forefront—subscribe for expert analysis and emerging trends in retinal disease management.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Modern Retina
1
AAO 2025: Ashkan Abbey on the outcomes of EYP-1901 for AMD and DME
2
Leadership in action during the 2025 AAO named lectures
3
Empowerment through education: Q&A with Inder Paul Singh, MD
4
Abeona Therapeutics’ ABO-503 chosen for FDA's Rare Disease Endpoint Advancement Pilot Program
5